Nuo Therapeutics, Inc. announced that it has engaged Winter Harbor LLC to assist the company in its financial restructuring process. In connection with the engagement, Mr. Shaun Martin, a principal at Winter Harbor, has been appointed Chief Restructuring Officer of Nuo effective December 15, 2015, and will report directly to its Board of Directors. Mr. Martin is a co-founder of Winter Harbor LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 USD | -10.81% |
|
+3.48% | -40.00% |
May. 20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
May. 15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 15M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics Announces Appointment of Shaun Martin as Chief Restructuring Officer Effective December 15, 2015